Cognistat

Cognistat is a private healthcare diagnostics company commercializing clinician-administered cognitive assessment tools for use in neuropsychology, neurology, psychiatry, geriatrics, rehabilitation, and related care settings. Its flagship products include the original 20-minute multi-domain Cognistat test, the shorter Cognistat Five screening test, and the web-based Cognistat Assessment System (CAS-II). The company focuses on rapid screening and profiling of cognitive deficits across domains such as language, memory, calculation, constructional ability, and reasoning. Cognistat is used to help evaluate patients with suspected delirium, mild cognitive impairment, dementia, stroke, traumatic brain injury, and other neurologic or psychiatric conditions. The business appears to be centered on commercial test kits, digital assessment workflows, and multilingual distribution rather than therapeutic drug development.